应对新冠肺炎期间武汉市接受抗病毒治疗艾滋病患者缺药风险评估

Antiretrovial Treatment Discontinuation Risk Assessment of HIV/AIDS Patients in Wuhan During the response of COVID-19

目的探索特殊情况下艾滋病患者抗病毒治疗药物保障措施。方法应对新型冠状病毒肺炎(简称新冠肺炎)期间采用电话调查的方法了解2020年1月1日至3月8日武汉市艾滋病患者抗病毒治疗药物领取情况,根据调查结果评估并解决其缺药风险。结果截至3月8日,武汉市正在接受抗病毒治疗艾滋病患者5517人,经评估5095人(92.35%)未来15天无缺药风险,228人(4.13%)缺药低风险,194人(3.52%)已缺药。疫情应对期间共4500人领药,其中2084人(46.31%)门诊自行取药,157人(3.49%)通过疾病预防控制中心或防艾志愿者上门送药获得药物,1735人(38.56%)通过邮寄方式获得药物,524人(11.64%)外地门诊借药。结论应对新冠肺炎期间,武汉市在治艾滋病患者存在缺药风险,但通过设立应急制度并提供多种取药途径,有效降低了缺药风险人群比例。

Objective To explore antiretroviral medicine safeguards for HIV/AIDS patients in extreme conditions.Methods We used a telephone survey to investigate the antiretroviral treatment situation of HIV/AIDS patients in Wuhan from January 1 st to March 8th,2020,assessed and solved the risk of ART discontinuation for these HIV/AIDS patients.Results A total of 5517 HIV/AIDS patients were receiving antiviral treatment in Wuhan until March 8th.We found that 92.35%of them with no risk of ART discontinuation,4.13%facing the risk of discontinuation in the next 15 days and 3.52%had discontinued.During the response of COVID-19,4500 people received antiretroviral medicines.2084(46.31%)of them went to the clinic for their medicines,157(3.49%)were delivered by local CDC or social volunteers,1735(38.56%)received the medicines by express delivery and 524(11.64%)borrowed medicine from other cities.Conclusion Although the supply of antiretroviral drugs against HIV have been disrupted during the pandemic of COVID-19 in Wuhan,the proportion of patients with ART discontinued has been effectively reduced by setting up an emergency system and providing a variety manners of drug access.